
Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into…

Rivia is a unified data and AI analytics platform designed for biotech and pharmaceutical companies to optimize clinical trials. It integrates fragmented trial data from multiple vendor sources into…
What they do: Unified clinical-trial data & AI analytics platform (Rivia Core, Rivia Detect, Rivia Spark) for biotech and pharma
Headquarters: Zürich, Switzerland
Founding year: 2022
Stage / recent raise: Series A reported March 2026 (~€13M / ~$14.7M)
Notable investors: Earlybird, Speedinvest, Amino Collective, Nina Capital, Defiant
Clinical trial data fragmentation, data quality and slow decision-making in drug development.
2022
Software Development
€3,000,000
Reported seed round (~€3M) with participation from Speedinvest, Amino Collective and Nina Capital.
€13,000,000
Series A reported March 2026; reported amounts vary (~€13M / €14.7M reported in some coverage).
“Participation from European VCs (Earlybird, Speedinvest, Amino Collective, Nina Capital, Defiant) indicates institutional VC backing and cross-border investor interest”
About Rivia
Rivia is a data engine for clinical trial intelligence. It provides data infrastructure and AI-driven workflows for clinical trial teams, enabling biotechs to run studies more efficiently and to demonstrate which patients derive the greatest benefit from new therapies. Biopharma companies are the source of most therapeutic innovation, yet clinical development is frequently slowed by fragmented data and outdated tooling. Rivia delivers a real-time, integrated view across clinical trial data, improving both trial execution and the evaluation of new treatments.
Our goal is for Rivia to become the new standard infrastructure for modern drug development, bringing new therapies to market more successfully at a fraction of the cost.
About AI Engineering at Rivia
Given the highly complex nature of clinical trials and how they interface with our technology, the AI Engineering team at Rivia is pivotal in ensuring our clients achieve their desired outcomes and derive maximum value from our platform.
Your next opportunity is in here somewhere. Sign up to explore 70,000+ startups and their open roles. No spam. No gamification. Just jobs.
70,000+
Startups
80,000+
Open Roles
3,900+
New This Week
| Company |
|---|
The team designs and operates agentic, production-grade AI workflows that power critical monitoring, data quality, and insight-generation capabilities for clinical trial stakeholders.
By building reliable, auditable, and scalable AI systems, AI Engineering helps transform fragmented clinical data into actionable intelligence and positions Rivia as the AI-first platform for clinical trial intelligence.
The Role
As a Senior AI Engineer at Rivia, you will architect and ship high-impact AI workflows that materially improve how clinical trial teams monitor studies, assess data quality, and make operational decisions.
You will work as a key technical contributor embedded in product initiatives, owning AI features end-to-end from design and evaluation through to deployment, observability, and continuous improvement.
The ideal candidate is a product-minded engineer who combines deep LLM and agentic systems expertise with strong software engineering skills, a bias to action, and a passion for turning cutting-edge AI into reliable, commercially impactful products in a complex, regulated domain.
Working Model: This role is based on-site in our Zürich office
What excites you
Responsibilities
What Excites us
Our Values
At Rivia, we are committed to excellence, continuous learning, and the success of both our customers and our team. If you are driven to exceed targets, eager to shape the future of clinical trials, and passionate about making a meaningful difference in the biotech industry, Rivia is the place for you.